Lv1
20 积分 2021-11-27 加入
Cryptic but critical: non-canonical antigens in cancer immunotherapy
3小时前
待确认
IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast Cancer
1个月前
已完结
Interferon-induced senescent CD8 + T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancer
4个月前
已完结
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
6个月前
已完结
First-Line Camizestrant for Emerging ESR1 -Mutated Advanced Breast Cancer
6个月前
已完结
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
7个月前
已完结
皖公网安备34019202002308
